X4 Pharmaceuticals Inc (NASDAQ: XFOR) is 72.93% higher on its value in year-to-date trading and has touched a low of $0.57 and a high of $2.58 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The XFOR stock was last observed hovering at around $1.46 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $1.45, the stock is 44.11% and 58.92% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.07 million and changing -0.68% at the moment leaves the stock 26.99% off its SMA200. XFOR registered 72.64% gain for a year compared to 6-month loss of 38.10%. The firm has a 200-day simple moving average (SMA200) of -$1.99.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 52.44% gain in the last 1 month and extending the period to 3 months gives it a 100.44%, and is 49.36% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 16.72% over the week and 10.43% over the month.
X4 Pharmaceuticals Inc (XFOR) has around 93 employees, a market worth around $243.51M and $0.00M in sales. Distance from 52-week low is 153.36% and -43.69% from its 52-week high. The company has generated returns on investments over the last 12 months (-93.43%).
X4 Pharmaceuticals Inc quarterly earnings per share for the current quarter are estimated at -$0.15.The EPS is expected to grow by 24.85% this year.
X4 Pharmaceuticals Inc (XFOR) Top Institutional Holders
118 institutions hold shares in X4 Pharmaceuticals Inc (XFOR), with institutional investors hold 61.89% of the company’s shares. The shares outstanding are 167.43M, and float is at 121.91M with Short Float at 11.81%. Institutions hold 61.37% of the Float.
The top institutional shareholder in the company is Bain Capital Life Sciences Investors, LLC with over 16.92 million shares valued at $24.53 million. The investor’s holdings represent 10.07% of the XFOR Shares outstanding. As of Dec 30, 2023, the second largest holder is NEA Management Company, LLC with 14.99 million shares valued at $21.73 million to account for 8.92% of the shares outstanding. The other top investors are Blackrock Inc. which holds 8.42 million shares representing 5.01% and valued at over $12.21 million, while Vanguard Group Inc holds 4.77% of the shares totaling 8.01 million with a market value of $11.61 million.
X4 Pharmaceuticals Inc (XFOR) Insider Activity
The most recent transaction is an insider sale by Mostafa Adam S.,the company’sChief Financial Officer. SEC filings show that Mostafa Adam S. sold 52,500 shares of the company’s common stock on Mar 11 ’24 at a price of $0.88 per share for a total of $46347.0. Following the sale, the insider now owns 0.0 shares.
X4 Pharmaceuticals Inc disclosed in a document filed with the SEC on Mar 11 ’24 that Ragan Paula (President and CEO) sold a total of 49,678 shares of the company’s common stock. The trade occurred on Mar 11 ’24 and was made at $0.88 per share for $43856.0. Following the transaction, the insider now directly holds 0.77 million shares of the XFOR stock.
Still, SEC filings show that on Mar 11 ’24, DiBiase Mary (Chief Operating Officer) disposed off 15,409 shares at an average price of $0.88 for $13591.0. The insider now directly holds 291,752 shares of X4 Pharmaceuticals Inc (XFOR).
